TY - JOUR
T1 - CD8+IL-17+ T cells mediate neutrophilic airway obliteration in T-bet-deficient mouse lung allograft recipients
AU - Lendermon, Elizabeth A.
AU - Dodd-O, Jeffrey M.
AU - Coon, Tiffany A.
AU - Miller, Hannah L.
AU - Ganguly, Sudipto
AU - Popescu, Iulia
AU - O'Donnell, Christopher P.
AU - Cardenes, Nayra
AU - Levine, Melanie
AU - Rojas, Mauricio
AU - Weathington, Nathaniel M.
AU - Zhao, Jing
AU - Zhao, Yutong
AU - McDyer, John F.
N1 - Publisher Copyright:
Copyright © 2015 by the American Thoracic Society.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - Acute cellular rejection is a known risk factor for the development of obliterative bronchiolitis, which limits the long-term survival of lung transplant recipients. However, the T cell effector mechanisms in both of these processes remain incompletely understood. Using the mouse orthotopic lung transplant model, we investigated whether C57BL/6 T-bet-/- recipients of major histocompatibility complex (MHC)-mismatched BALB/c lung grafts develop rejection pathology and allospecific cytokine responses that differ from wild-type mice. T-bet-/- recipients demonstrated vigorous allograft rejection at 10 days, characterized by neutrophilic inflammation and predominantly CD8+ T cells producing allospecific IL-17 and/or IFN-γ, in contrast to IFN-γ-dominant responses in WT mice. CD4+ T cells produced IL-17 but not IIN-γ responses in T-bet-/- recipients, in contrast to WT controls. Costimulation blockade using anti-CD154 Ab significantly reduced allospecific CD8+IFN-7+ responses in both T-bet-/- and W mice but had no attenuating effect on lung rejection pathology in T-bet-/- recipients or on the development of obliterative airway inflammation that occurred only in T-bet-/- recipients. However, neutralization of IL-17A significantly attenuated costimulation blockade-resistant rejection pathology and airway inflammation in T-bet-/- recipients. In addition, CXCL1 (neutrophil chemokine) was increased in T-bet-/- allografts, and IL-17 induced CXCL1 from mouse lung epithelial cells in vitro. Taken together, our data show that T-bet-deficient recipients of complete MHC-mismatched lung allografts develop costimulation blockade-resistant rejection characterized by neutrophilia and obliterative airway inflammation that is predominantly mediated by CD8+ IL-17+ T cells. Our data support T-bet-deficient mouse recipients of lung allografts as a viable animal model to study the immunopathogenesis of small airway injury in lung transplantation.
AB - Acute cellular rejection is a known risk factor for the development of obliterative bronchiolitis, which limits the long-term survival of lung transplant recipients. However, the T cell effector mechanisms in both of these processes remain incompletely understood. Using the mouse orthotopic lung transplant model, we investigated whether C57BL/6 T-bet-/- recipients of major histocompatibility complex (MHC)-mismatched BALB/c lung grafts develop rejection pathology and allospecific cytokine responses that differ from wild-type mice. T-bet-/- recipients demonstrated vigorous allograft rejection at 10 days, characterized by neutrophilic inflammation and predominantly CD8+ T cells producing allospecific IL-17 and/or IFN-γ, in contrast to IFN-γ-dominant responses in WT mice. CD4+ T cells produced IL-17 but not IIN-γ responses in T-bet-/- recipients, in contrast to WT controls. Costimulation blockade using anti-CD154 Ab significantly reduced allospecific CD8+IFN-7+ responses in both T-bet-/- and W mice but had no attenuating effect on lung rejection pathology in T-bet-/- recipients or on the development of obliterative airway inflammation that occurred only in T-bet-/- recipients. However, neutralization of IL-17A significantly attenuated costimulation blockade-resistant rejection pathology and airway inflammation in T-bet-/- recipients. In addition, CXCL1 (neutrophil chemokine) was increased in T-bet-/- allografts, and IL-17 induced CXCL1 from mouse lung epithelial cells in vitro. Taken together, our data show that T-bet-deficient recipients of complete MHC-mismatched lung allografts develop costimulation blockade-resistant rejection characterized by neutrophilia and obliterative airway inflammation that is predominantly mediated by CD8+ IL-17+ T cells. Our data support T-bet-deficient mouse recipients of lung allografts as a viable animal model to study the immunopathogenesis of small airway injury in lung transplantation.
KW - Acute rejection
KW - IL-17
KW - Mouse orthotopic lung transplant
KW - Neutrophils
KW - T-bet
UR - http://www.scopus.com/inward/record.url?scp=84929494025&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929494025&partnerID=8YFLogxK
U2 - 10.1165/rcmb.2014-0059OC
DO - 10.1165/rcmb.2014-0059OC
M3 - Article
C2 - 25286244
AN - SCOPUS:84929494025
SN - 1044-1549
VL - 52
SP - 622
EP - 633
JO - American journal of respiratory cell and molecular biology
JF - American journal of respiratory cell and molecular biology
IS - 5
ER -